Interleukin-2 in Treating Patients With Mycosis Fungoides
Completed · Phase 1
Conditions studied: Lymphoma
In brief
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-2 in treating patients who have mycosis fungoides.
Key facts
- Study ID
- NCT00002687
- Run by
- University of Washington
- People needed
- 30
- Starts
- 1995-02-01
- Expected to finish
- 2003-07-01
- Last updated by the study team
- 2012-12-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Washington Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.